United States · Venture startup
2 rounds we have observed, with the 8 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$51Mraised across 2 rounds since 2008, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
VantagePoint Capital Partners
Sofinnova Investments
Pappas VenturesFrom a historical funding record
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
From historical deal records. Wrong? Tell us.
Missing a round, or an investor who was in one? Tell us.
Anthera Pharmaceuticals's investors include OrbiMed, VantagePoint Capital Partners, Sofinnova Investments, Pappas Ventures and Caxton Advantage Life Sciences Fund, and 3 more on record.
Anthera Pharmaceuticals has raised $51M across 2 rounds since 2008.
Anthera Pharmaceuticals's most recent round was a Venture of $32M in Sept 2010.
Its most recent round, $32M in Sept 2010, is also its largest on record.
Anthera Pharmaceuticals's first round on record, in Aug 2008, was backed by VantagePoint Capital Partners, Sofinnova Investments and Pappas Ventures and 3 others.
Anthera Pharmaceuticals's latest named round is a Venture, in Sept 2010.
Anthera Pharmaceuticals is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
